Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

L.A. McKeown

December 21, 2018

News Daily News

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

Shelley Wood

December 18, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Daily News

Low Temps, Harsh Weather Linked to MI Risk, Swedish Study Confirms

Caitlin E. Cox

October 25, 2018

News Daily News

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Yael L. Maxwell

October 23, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

Todd Neale

October 17, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Daily News

DET02X-AMI: Oxygen Takes Another Hit as More Data Show No Pain Relief During PCI

L.A. McKeown

August 30, 2018

News Conference News ESC 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

Shelley Wood

August 29, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Daily News

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

Michael O'Riordan

August 14, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Daily News

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

Todd Neale

August 01, 2018

News Conference News SCCT 2018

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

Yael L. Maxwell

July 18, 2018

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

L.A. McKeown

June 22, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Caitlin E. Cox

May 31, 2018

News Conference News EuroPCR 2018

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

Yael L. Maxwell

May 30, 2018

Advertisement

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Low Temps, Harsh Weather Linked to MI Risk, Swedish Study Confirms

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

DET02X-AMI: Oxygen Takes Another Hit as More Data Show No Pain Relief During PCI

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

High-Sensitivity Troponin T Safely Rules Out More MI Patients, and Faster, Than Conventional Assay

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content